Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07096011 · ClinicalTrials.gov registry record

Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants

A clinical trial of Metabolism and Energy Expenditure, sponsored by Pennington Biomedical Research Center.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT07096011 is a study of Metabolism and Energy Expenditure that is actively recruiting participants, run by Pennington Biomedical Research Center. The registered enrollment target is 40 participants, below the 13,264-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07096011, a study of Metabolism and Energy Expenditure, is actively recruiting participants, sponsored by Pennington Biomedical Research Center.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to understand how infants metabolize different meals and to develop clinical tools which identify infants as having two different phenotypes. The phenotypes are the 1) metabolic "thriftiness" and 2) the metabolic flexibility.

Interventions

  • OTHER Meal Test - Human Milk
  • OTHER Meal Test - Infant Formula

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-07-28
Est. Completion 2027-05

What the Registry Record Tells You About NCT07096011

The ClinicalTrials.gov registry entry for NCT07096011 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 13,264-participant average among 19 other Metabolism trials with a reported enrollment target (100% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Metabolism appearing as the primary indexed condition, and to 2 interventions - of which Meal Test - Human Milk is the first listed.

NCT07096011 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT07096011 about?

NCT07096011 is a clinical study titled "Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants". The purpose of this research study is to understand how infants metabolize different meals and to develop clinical tools which identify infants as having two different phenotypes. The phenotypes are the 1) metabolic "thriftiness" and 2) the metabolic flexibility.

What is the current status of trial NCT07096011?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-07-28. Estimated completion is 2027-05.

What conditions does trial NCT07096011 study?

This clinical trial studies the following conditions: Metabolism, Energy Expenditure, Infant Body Composition and Metabolism, Infant Formula, Human Milk, Breast Milk.

What interventions are being tested in trial NCT07096011?

The interventions under investigation include: Meal Test - Human Milk (OTHER), Meal Test - Infant Formula (OTHER).

Who is sponsoring clinical trial NCT07096011?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07096011 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.